Center for Financial Planning’s Teva Pharmaceuticals TEVA Stock Holding History

Center for Financial Planning’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.39K	Hold	100	–	–	﹤0.01%	562
2026 Q1	$3.01K	Hold	100	–	–	﹤0.01%	556
2025 Q4	$3.12K	Hold	100	–	–	﹤0.01%	586
2025 Q3	$2.02K	Hold	100	–	–	﹤0.01%	593
2025 Q2	$1.68K	Hold	100	–	–	﹤0.01%	573
2025 Q1	$1.54K	Hold	100	–	–	﹤0.01%	607
2024 Q4	$2.2K	Hold	100	–	–	﹤0.01%	530
2024 Q3	$1.8K	Hold	100	–	–	﹤0.01%	501
2024 Q2	$1.63K	Hold	100	–	–	﹤0.01%	506
2024 Q1	$1.41K	Hold	100	–	–	﹤0.01%	543
2023 Q4	$1.04K	Hold	100	–	–	﹤0.01%	482
2023 Q3	$1.02K	Hold	100	–	–	﹤0.01%	480
2023 Q2	$753	Hold	100	–	–	﹤0.01%	530
2023 Q1	$885	Hold	100	–	–	﹤0.01%	484
2022 Q4	$912	Hold	100	–	–	﹤0.01%	488
2022 Q3	$1K	Sell	100 -1,000	-91%	-$8.84K	﹤0.01%	620
2022 Q2	$8K	Hold	1,100	–	–	﹤0.01%	386
2022 Q1	$10K	Hold	1,100	–	–	﹤0.01%	373
2021 Q4	$9K	Hold	1,100	–	–	﹤0.01%	397
2021 Q3	$11K	Hold	1,100	–	–	﹤0.01%	353
2021 Q2	$11K	Hold	1,100	–	–	﹤0.01%	354
2021 Q1	$13K	Hold	1,100	–	–	﹤0.01%	357
2020 Q4	$11K	Buy	1,100 +1,000	+1,000%	+$9.58K	﹤0.01%	336
2020 Q3	$1K	Hold	100	–	–	﹤0.01%	432
2020 Q2	$1K	Hold	100	–	–	﹤0.01%	437
2020 Q1	$1K	Hold	100	–	–	﹤0.01%	556
2019 Q4	$1K	Buy	+100	New	+$893	﹤0.01%	449

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Center for Financial Planning's TEVA Position: Q2 2026 in Review

Center for Financial Planning held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 100 shares worth $3.39K. The position accounts for ﹤0.01% of the portfolio, ranked #562.

Center for Financial Planning first reported a position in TEVA in Q4 2019 and has held it in 27 quarters since. The position peaked at $13K in Q1 2021. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Center for Financial Planning held 100 shares of Teva Pharmaceuticals worth $3.39K as of Q2 2026.
Center for Financial Planning left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up ﹤0.01% of Center for Financial Planning's portfolio in Q2 2026, its #562 holding.
Center for Financial Planning first reported a position in Teva Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
Center for Financial Planning's Teva Pharmaceuticals position peaked at $13K in Q1 2021.
675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Center for Financial Planning's 13F filing for Q2 2026, filed 21 Jul 2026.